Drug Shortage Report for OCTASA

Last updated on 2026-03-09

Report ID 277142
Drug Identification Number 02465752
Brand name OCTASA
Common or Proper name Mesalazine
Company Name TILLOTTS PHARMA AG
Market Status MARKETED
Active Ingredient(s) MESALAZINE
Strength(s) 800MG
Dosage form(s) TABLET (DELAYED-RELEASE)
Route of administration ORAL
Packaging size 180
ATC code A07EC
ATC description INTESTINALANTIINFLAMMATORY AGENTS
Reason for shortage Other (Please describe in comments)
Anticipated start date 2026-01-25
Actual start date 2026-01-26
Estimated end date 2026-02-23
Actual end date 2026-03-06
Shortage status Resolved
Updated date 2026-03-09
Company comments Delay in production
Health Canada comments
Tier 3 Status No
Contact Address BASLERSTRASSE 15
RHEINFELDEN, AARGAU
SWITZERLAND 4310
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v14 2026-03-09 French Compare
v13 2026-03-09 English Compare
v12 2026-03-06 French Compare
v11 2026-03-06 English Compare
v9 2026-03-06 English Compare
v10 2026-03-06 English Compare
v8 2026-03-06 English Compare
v7 2026-03-06 French Compare
v6 2026-03-06 English Compare
v4 2026-03-06 English Compare
v5 2026-03-06 English Compare
v3 2026-02-03 French Compare
v2 2026-02-03 English Compare
v1 2026-02-03 English Compare

Showing 1 to 14 of 14